Additionally, Powell et al. attributed stable numbers of CD27+CD28+ tumor reactive T cells to contribute to the development of long-term, melanoma-reactive memory CD8+ T cells and eradication of melanoma tumors in patients [141]. This evidence concerns the gene CD28 and melanoma.